TITLE:
Incidence, Clinical Presentation and Angiographic Findings among Patients with Coronary Artery Ectasia in Gaza
AUTHORS:
Mohammed Habib
KEYWORDS:
CAE, STEMI, Non-STE-ACS, Stable Angina Pectoris
JOURNAL NAME:
Health,
Vol.16 No.3,
March
28,
2024
ABSTRACT: Background: Coronary artery ectasia (CAE) is a rare form of
aneurysmal coronary heart disease. This condition increases risk of ischemia
that leaded to stable angina pectoris and also acute coronary syndrome. Objective: To
evaluate the incidence of CAE and to analyze clinical and angiographic characteristics among patients with symptomatic coronary artery
disease. Methods: Retrospective trial of diagnostic coronary angiography which was
performed at Alshifa hospital in Gaza, included
all patients with
coronary heart disease and underwent diagnostic coronary angiography from March
2014 to March 2023. We evaluate the incidence, clinical presentation and angiographic findings of patients with symptomatic coronary ectasia. Results: Of the 12,534
angiograms analyzed, CAE was found in 539 patients, an incidence of 4.3%. The
mean age was 59.2 ± 11.7 years, and male gender predominate 81.8%. A 285 (52.9%) of patients found to
have single ectatic vessel at their angiographic results. In two vessels 120
patients (22.3%), in three vessels 95 patients (17.6%) and in three vessel plus left main in 39 patients (7.2%). 70.9% angiograms showed pure ectasia without associated significant stenotic
lesions in the same vessel. The right coronary artery (RCA) was the commonest
affected vessel by ectasia. The most common presentation of patients is non ST
segment elevation acute coronary syndrome. Conclusion: The incidence of
coronary ectasia was 4.3%. Non ST
segment elevation acute
coronary syndrome was the most common clinical presenting. Only 30% of patients have additionally significant
coronary artery stenosis. The majority of patients had single vessel involvement and right
coronary artery was the most common involved vessel. Despite a dapper
understanding of CAE in last years, there are still come critical issues about optimal treatment. Large multicenter
randomized control trials are recommended to guide the clinician in the
management of this complex sitting of patients.